This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Catalent U.k. Swindon Zydis Limited, Mymetics Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 18 
2 out of 7 Years Active: 2022
Title: Innovations in Oral Vaccination: The Contributions of Antonius Johannes Hendrikus Stegmann
Introduction
Antonius Johannes Hendrikus Stegmann is a notable inventor based in Rijnsburg, Netherlands. With a total of two patents to his name, Stegmann has made significant contributions to the field of oral vaccination, particularly through his work with lipid-based vesicles, known as virosomes. His innovations aim to enhance vaccine delivery and stability, promising advancements in public health.
Latest Patents
Stegmann's latest patents focus on "Oral dispersible vaccine comprising virosomes." These patents disclose novel oral vaccine dosage forms and detail the processes for producing them. The dosage forms utilize lipid-based vesicles, including virosomes and liposomes, which contain an immunogenic amount of at least one vaccinal target molecule, with or without adjuvant. Notably, these innovations involve a unique combination of liquid virosome concentrates and the formulation base matrix, optimized under specific manufacturing conditions. This results in a freeze-dried sublingual dosage form that exhibits physical robustness and maintains particle and antigen integrity and stability.
Career Highlights
Throughout his career, Antonius Stegmann has worked with reputable companies, including Catalent UK Swindon Zydis Limited and Mymetics Corporation. His roles in these organizations have allowed him to leverage his expertise in the development of innovative vaccine technologies.
Collaborations
Stegmann has collaborated with talented individuals in the field, including his coworkers Yik Teng Wong and Charli Smardon. These collaborations have likely contributed to the progress and refinement of his patents, underscoring the importance of teamwork in advancing scientific research.
Conclusion
Antonius Johannes Hendrikus Stegmann is a prominent figure in the realm of vaccine innovation, with a focus on improving oral vaccination methods. Through his patents and collaborative efforts, he continues to push the boundaries of what is possible in the realm of immunization, paving the way for potential breakthroughs in public health. His work exemplifies the critical role of inventors in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile